International Society of Urological Pathology (ISUP) Multidisciplinary Consensus on Premalignant and Putative Precursor Lesions of Penile Cancer: Working Group 5 report on Terminology, Grading, and Molecular Testing Practices

  • 0Department of Pathology, Tata Memorial Centre and Homi Bhabha National Institute, Mumbai, Maharashtra, India.

|

|

Summary

This summary is machine-generated.

Pathologists reached consensus on classifying penile intraepithelial neoplasia (PeIN) by HPV status and using p16 IHC, but grading PeIN remains controversial, highlighting a need for standardization.

Area Of Science

  • Uropathology
  • Oncology
  • Molecular Pathology

Background

  • Penile intraepithelial neoplasia (PeIN) is a precursor to penile squamous cell carcinoma (PSCC), but its classification and diagnosis lack consistency among pathologists.
  • Current global practices in terminology, grading, and molecular testing for PeIN require assessment and standardization.

Purpose Of The Study

  • To establish consensus on the classification, grading, and molecular testing of penile intraepithelial neoplasia (PeIN).
  • To assess current global practices and achieve consensus among international experts on penile cancer precursor lesions.

Main Methods

  • A preconference survey was distributed to 112 International Society of Urological Pathology (ISUP) members.
  • Results were presented and consensus was achieved through electronic voting at the ISUP Multidisciplinary Consensus Conference in September 2024.

Main Results

  • 89.4% of respondents classify PeIN based on HPV association; 76% support subtyping.
  • A majority (82%) voted against grading PeIN, while p16 IHC is widely used (91.5%) for distinguishing HPV-associated PeIN.
  • p53 IHC and HPV genotyping lack consensus for routine use; reporting of PeIN margins and association with lichen sclerosis is endorsed.

Conclusions

  • This ISUP consensus paper standardizes PeIN classification, emphasizing HPV-related stratification and p16 IHC staining.
  • Significant variability persists in PeIN grading and molecular testing, necessitating further research and standardization for improved diagnostic accuracy and clinical relevance.